TERESA GAJEWSKI: Open Payments
NPI 1508142001 · APPLETON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 21 payments from 11 companies in 2025. Trend: 2023 $904 · 2024 $1,172 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $98 |
| PFIZER INC. | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: JARDIANCE, Wegovy, PREVNAR 20, MOUNJARO, CAPLYTA, ELIQUIS, TRINTELLIX, NURTEC ODT.
Industry payments across WI — which companies pay providers there.
